Dr. Kenneth Rockwood- How does ageing influence the diseases of ageing? The case of late-life dementia
Date: Tuesday,Feb 11th, 2020
Time: 3:00PMm
Location: BPK Seminar Room (K9622/9624)
Host: Dr. Angela Brooks-Wilson & Dr. Xiaowei Song
Objectives
At the end of the presentation, audience members should be able to:
- Consider ways in which understanding the diseases of late life might accommodate the fact that they rarely travel alone.
- Review a quantitative approach to measuring how age-related deficit accumulation - compared with chronological age, influences both the risk of dementia, and the degree of its expression.
- Critique how that conclusion, if viable, might influence dementia therapeutics.
Biography
Dr. Kenneth Rockwood, MD, FRCPC, FRCP, is Professor of Medicine (Geriatric Medicine & Neurology) and the Kathryn Allen Weldon Professor of Alzheimer Research at Dalhousie University. He is a leading authority on frailty. Ken received his MD from Memorial University in St. John鈥檚, NL, completed training in Internal Medicine at the University of Alberta, and in Geriatric Medicine from Dalhousie University. He also holds a Master鈥檚 degree in Public Administration (Queen鈥檚 University, Ontario). He serves on the Lancet Commission on Dementia, as an inaugural member of Canada鈥檚 National Council on Dementia, and on the Scientific Advisory Board of the Chinese National Center for Gerontology. He is the Associate Director of the Canadian Collaboration on Neurodegeneration in Aging.
Ken has published more than 500 peer-reviewed papers and ten books, including the eighth edition of Brocklehurst鈥檚 Textbook of Geriatric Medicine & Gerontology. In 2016 he received the China Friendship Award, that country鈥檚 highest honour for foreigners. Since 2017, facilitating his work with the National Health Service of England and Wales, he has held an appointment as Honorary Professor of Population Science and Experimental Medicine, University College London. Ken also founded and serves as the President and Chief Science Officer of DGI Clinical Inc., a spin-off company that focuses on individualized outcome measurement and advanced data analytics in several complex disease states. Most recently he has decided to become part of the problem. He has thus added to his dues by taking now the role of Senior Medical Director for Acute Medicine for the Nova Scotia Health Authority.